Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

NCT04819776 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

417

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar I Disorder

Interventions

DRUG: Iloperidone
DRUG: Iloperidone Placebo

Sponsor

Vanda Pharmaceuticals